1. Home
  2. MXCT vs TLS Comparison

MXCT vs TLS Comparison

Compare MXCT & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • TLS
  • Stock Information
  • Founded
  • MXCT 1999
  • TLS 1969
  • Country
  • MXCT United States
  • TLS United States
  • Employees
  • MXCT N/A
  • TLS N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TLS EDP Services
  • Sector
  • MXCT Health Care
  • TLS Technology
  • Exchange
  • MXCT Nasdaq
  • TLS Nasdaq
  • Market Cap
  • MXCT 239.2M
  • TLS 199.9M
  • IPO Year
  • MXCT 2021
  • TLS 2020
  • Fundamental
  • Price
  • MXCT $2.20
  • TLS $3.17
  • Analyst Decision
  • MXCT Strong Buy
  • TLS Buy
  • Analyst Count
  • MXCT 1
  • TLS 6
  • Target Price
  • MXCT $9.00
  • TLS $3.94
  • AVG Volume (30 Days)
  • MXCT 874.5K
  • TLS 854.0K
  • Earning Date
  • MXCT 08-05-2025
  • TLS 08-08-2025
  • Dividend Yield
  • MXCT N/A
  • TLS N/A
  • EPS Growth
  • MXCT N/A
  • TLS N/A
  • EPS
  • MXCT N/A
  • TLS N/A
  • Revenue
  • MXCT $37,675,000.00
  • TLS $109,269,000.00
  • Revenue This Year
  • MXCT $8.82
  • TLS $35.76
  • Revenue Next Year
  • MXCT $21.12
  • TLS $26.83
  • P/E Ratio
  • MXCT N/A
  • TLS N/A
  • Revenue Growth
  • MXCT N/A
  • TLS N/A
  • 52 Week Low
  • MXCT $2.00
  • TLS $1.83
  • 52 Week High
  • MXCT $5.20
  • TLS $4.82
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 51.61
  • TLS 71.70
  • Support Level
  • MXCT $2.00
  • TLS $2.37
  • Resistance Level
  • MXCT $2.28
  • TLS $2.69
  • Average True Range (ATR)
  • MXCT 0.12
  • TLS 0.16
  • MACD
  • MXCT 0.02
  • TLS 0.05
  • Stochastic Oscillator
  • MXCT 78.95
  • TLS 86.02

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: